Ten-year follow-up data from the Age-Related Eye Disease Study 2 (AREDS2) were reviewed for prevalence of visual hallucination and other symptoms characteristic of Charles Bonnet syndrome in older patients with AMD. Source: AAO
This week, an educational website on uveitic glaucoma is launched, patients express satisfaction with remote consultations, and a gene therapy trial for AMD enters phase III enrollment. Source: AAO
Records of patients with retinal vein occlusion (RVO) and poor visual acuity were assessed to determine the effectiveness of anti-VEGF therapy in this population.. Source: AAO
This study looked at the location at which vascular caliber is measured and its association with nonperfusion and diabetic retinopathy (DR) severity differences. Source: AAO
A narrative literature review of studies provide an overview of the adverse ocular effects reported with the 4 types of COVID-19 vaccine currently available. Source: AAO
Survey data reveal a gender compensation gap for the first year of practice for ophthalmologists and a gender difference in the success of compensation negotiations. Source: AAO
From facial swelling following the COVID-19 vaccine to a new approach to iridodialysis repair, here’s a look at the year’s most popular 1-Minute videos, clinical/surgical videos, and interviews. Source: AAO
Investigators reviewed records of patients treated at a single center with anti-VEGF for inflammatory choroidal neovascularization (CNV) to determine the long-term effects, particularly features seen on OCT. Source: AAO
Researchers used conjunctival swabs to collect tears from eyes within 48 hours of confirmation of the virus RNA in patients with moderate to severe COVID-19 and found evidence of a higher possibility of viral transmission. Source: AAO
In this large study of 10,114 patients, rates of reoperation were studied for patients with idiopathic epiretinal membrane (ERM) who received pars plana vitrectomy with or without inner limiting membrane (ILM) peeling. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
